JP2023536995A5 - - Google Patents
Info
- Publication number
- JP2023536995A5 JP2023536995A5 JP2023507949A JP2023507949A JP2023536995A5 JP 2023536995 A5 JP2023536995 A5 JP 2023536995A5 JP 2023507949 A JP2023507949 A JP 2023507949A JP 2023507949 A JP2023507949 A JP 2023507949A JP 2023536995 A5 JP2023536995 A5 JP 2023536995A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- polypeptide
- amino acid
- immunotherapy composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063062919P | 2020-08-07 | 2020-08-07 | |
| US63/062,919 | 2020-08-07 | ||
| PCT/US2021/045062 WO2022032166A1 (en) | 2020-08-07 | 2021-08-06 | Multiepitope vaccine for the treatment of alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536995A JP2023536995A (ja) | 2023-08-30 |
| JP2023536995A5 true JP2023536995A5 (enExample) | 2025-08-19 |
Family
ID=80118546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507949A Pending JP2023536995A (ja) | 2020-08-07 | 2021-08-06 | アルツハイマー病を処置するためのマルチエピトープワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250186567A1 (enExample) |
| EP (1) | EP4192497A4 (enExample) |
| JP (1) | JP2023536995A (enExample) |
| KR (1) | KR20230080397A (enExample) |
| CN (1) | CN116472055A (enExample) |
| AR (1) | AR123188A1 (enExample) |
| AU (1) | AU2021321549A1 (enExample) |
| CA (1) | CA3188456A1 (enExample) |
| IL (1) | IL300347A (enExample) |
| MX (1) | MX2023001503A (enExample) |
| TW (1) | TW202221017A (enExample) |
| WO (1) | WO2022032166A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| BR112022023366A2 (pt) * | 2020-05-19 | 2023-05-02 | Othair Prothena Ltd | Vacina com múltiplos epítopos para o tratamento de mal de alzheimer |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| CN116438191A (zh) * | 2020-09-18 | 2023-07-14 | 欧萨尔普罗席纳有限公司 | 治疗阿尔茨海默病之多表位疫苗 |
| CU20230023A7 (es) | 2023-05-12 | 2024-12-09 | Ct Ingenieria Genetica Biotecnologia | Antígeno quimérico multiblanco para la inmunoterapia de la enfermedad de alzheimer |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208036A (en) | 1985-01-07 | 1993-05-04 | Syntex (U.S.A.) Inc. | N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
| US5674703A (en) | 1992-12-02 | 1997-10-07 | Woo; Savio L. C. | Episomal vector systems and related methods |
| DE69435171D1 (de) | 1993-09-14 | 2009-01-08 | Pharmexa Inc | Pan dr-bindeproteinen zur erhöhung der immunantwort |
| US5505947A (en) | 1994-05-27 | 1996-04-09 | The University Of North Carolina At Chapel Hill | Attenuating mutations in Venezuelan Equine Encephalitis virus |
| US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
| DK1005368T3 (da) | 1997-03-10 | 2010-01-04 | Ottawa Hospital Res Inst | Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| WO2004044195A2 (en) * | 2002-11-12 | 2004-05-27 | Risø National Laboratory | Polynucleotides encoding agmatine coumaroyltransferase (act) and uses thereof |
| WO2008081008A1 (en) | 2007-01-05 | 2008-07-10 | University Of Zurich | Method of providing disease-specific binding molecules and targets |
| ME03008B (me) * | 2011-09-19 | 2018-10-20 | Axon Neuroscience Se | Terapija na osnovu proteina i dijagnoza patologije u којој posreduje tau u alcнajмerovoj bolesti |
| EP2887955B1 (en) * | 2012-08-21 | 2020-08-19 | Institute for Molecular Medicine, Inc. | Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein |
| US10501531B2 (en) | 2013-03-13 | 2019-12-10 | Prothena Biosciences Limited | Tau immunotherapy |
| CN108778289B (zh) | 2015-11-06 | 2020-11-17 | 佐剂技术公司 | 三萜皂苷类似物 |
| MX2018013386A (es) | 2016-05-02 | 2019-02-28 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau. |
| PT3452507T (pt) | 2016-05-02 | 2022-12-20 | Prothena Biosciences Ltd | Imunoterapia anti-tau |
| MY198194A (en) | 2016-05-02 | 2023-08-09 | Prothena Biosciences Ltd | Antibodies Recognizing Tau |
| WO2018191598A1 (en) | 2017-04-13 | 2018-10-18 | Adjuvance Technologies, Inc. | Triterpene saponin synthesis, intermediates and adjuvant combinations |
| US20200164065A1 (en) | 2017-04-25 | 2020-05-28 | Adjuvance Technologies, Inc. | Triterpene saponin analogues |
| KR102784294B1 (ko) | 2017-05-02 | 2025-03-19 | 프로테나 바이오사이언시즈 리미티드 | 타우 인식 항체 |
| SG11202001826YA (en) | 2017-10-16 | 2020-03-30 | Adjuvance Technologies Inc | Triterpene saponin analogues |
| GB201803387D0 (en) * | 2018-03-02 | 2018-04-18 | One Health Ventures Ltd | Disease detection |
| CN109022460B (zh) * | 2018-08-31 | 2021-05-28 | 西藏自治区农牧科学院农业研究所 | 一种bahd酰基转移酶基因及其用途 |
-
2021
- 2021-08-06 WO PCT/US2021/045062 patent/WO2022032166A1/en not_active Ceased
- 2021-08-06 KR KR1020237007790A patent/KR20230080397A/ko active Pending
- 2021-08-06 CN CN202180067903.XA patent/CN116472055A/zh active Pending
- 2021-08-06 US US18/020,034 patent/US20250186567A1/en active Pending
- 2021-08-06 CA CA3188456A patent/CA3188456A1/en active Pending
- 2021-08-06 IL IL300347A patent/IL300347A/en unknown
- 2021-08-06 EP EP21853506.0A patent/EP4192497A4/en active Pending
- 2021-08-06 MX MX2023001503A patent/MX2023001503A/es unknown
- 2021-08-06 JP JP2023507949A patent/JP2023536995A/ja active Pending
- 2021-08-06 AU AU2021321549A patent/AU2021321549A1/en active Pending
- 2021-08-09 AR ARP210102219A patent/AR123188A1/es unknown
- 2021-08-09 TW TW110129345A patent/TW202221017A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023536995A5 (enExample) | ||
| JP2023526500A5 (enExample) | ||
| JP2023541670A5 (enExample) | ||
| JP2023541669A5 (enExample) | ||
| TWI379839B (en) | Aβ immunogenic peptide carrier conjugates and methods of producing same | |
| TWI355390B (en) | Immunogenic peptide carrier conjugates and methods | |
| JP2023536746A5 (enExample) | ||
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| CA2167730A1 (en) | Synthetic multiple tandem repeat mucin and mucin-like peptides and uses thereof | |
| US9849174B2 (en) | Methods and compositions related to immunogenic fibrils | |
| JP2012523379A (ja) | 免疫原性組成物およびその使用 | |
| JP2023541671A5 (enExample) | ||
| CN101557821B (zh) | 作为疟疾疫苗的恶性疟原虫表面蛋白的偶联物 | |
| WO2010005858A1 (en) | Vaccine for the treatment of alzheimer's disease | |
| TW202212348A (zh) | 用於治療阿茲海默症之β類澱粉蛋白疫苗 | |
| US20030175285A1 (en) | Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid | |
| JP2022514411A (ja) | リポペプチドビルディングブロックおよび合成ウイルス様粒子 | |
| JP2023541670A (ja) | アルツハイマー病の処置のためのマルチエピトープワクチン | |
| TW202221022A (zh) | 用於治療阿茲海默症之ｔａｕ疫苗 | |
| KR20220062080A (ko) | 전립선암 치료를 위한 면역요법 | |
| US20230287050A1 (en) | Immunogenic Compounds | |
| JP2023541671A (ja) | シヌクレイノパチーの処置のためのアルファ－シヌクレインワクチン | |
| US20100266623A1 (en) | Synthetic, self adjuvanting vaccines | |
| US20110262473A1 (en) | Synthetic vaccine component | |
| KR100887591B1 (ko) | 특정의 교차 반응성을 증가시키는 항원성 구조들의 제조방법 |